Beksac, Meral2025-04-182025-04-182024Beksac, M. (2024). Daratumumab maintenance in patients with myeloma. The Lancet Oncology, 25(8), 947-948.1470-20451474-5488http://dx.doi.org/10.1016/S1470-2045(24)00341-3https://hdl.handle.net/20.500.12713/7141Daratumumab maintenance in patients with myelomaeninfo:eu-repo/semantics/closedAccessDaratumumab maintenance in patients with myelomaOther25894794838889736WOS:0012827208000012-s2.0-85197069468Q110.1016/S1470-2045(24)00341-3Q1